Kevin Haynes, PharmD, MSCE

Johnson & Johnson

Poster(s):

• (131) Changes in Incidence and Characteristics of Juvenile Idiopathic Arthritis Diagnoses from ICD-9-CM to ICD-10-CM
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (285) Capacity for Identifying Janssen Ad26.COV2.S COVID-19 Vaccination in Four US Health Insurance and State Immunization Information System Databases: Preparation for a Post Authorization Safety Study
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (188) Healthcare Utilization and Treatment Among Newly Diagnosed and Prevalent Children with Juvenile Idiopathic Arthritis During the First Year of COVID-19 Pandemic in the US
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST